Differential liver protein expression during schistosomiasis

Infection and Immunity

Volumn 75, Issue 2, 2007, Pages 736-744

  Harvie, Marina ^a   Jordan, Thomas William ^a   La Flamme, Anne Camille ^a  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITATE HYDRATASE; ALBUMIN; ALDEHYDE DEHYDROGENASE; APOLIPOPROTEIN A1; ARGINASE; ARGINASE 1; BETA ACTIN; CALRETICULIN; CATALASE; CHAPERONIN; CYTOKERATIN; FRUCTOSE BISPHOSPHATASE; GALECTIN 1; GLUCOSE REGULATED PROTEIN 78; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; HEAT SHOCK PROTEIN; LACTATE DEHYDROGENASE; LIVER PROTEIN; METHIONINE ADENOSYLTRANSFERASE; PEROXIREDOXIN; PEROXIREDOXIN 1; PROTEIN DISULFIDE ISOMERASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SUCCINYL COENZYME A SYNTHETASE; THIOREDOXIN; TRANSFERRIN; TROPOMYOSIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIMENTIN;

ACUTE PHASE RESPONSE; ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CITRIC ACID CYCLE; FEMALE; LIVER FIBROSIS; LIVER FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; STRESS; UREA CYCLE;

ANIMALS; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; LIVER; MICE; MICE, INBRED C57BL; PROTEINS; PROTEOME; SCHISTOSOMIASIS MANSONI; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33846808872     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01048-06     Document Type: Article

References (74)

1. Ahmed, S. A., and M. Z. Gad. 1996. Diagnostic value of serum lactate dehydrogenase isoenzyme and amino acid patterns in several schistosomal and non-schistosomal disorders as compared to other biochemical parameters. Dis. Markers 13:19-29.
2. Amacher, D. E. 2002. A toxicologist's guide to biomarkers of hepatic response. Hum. Exp. Toxicol. 21:253-262.
3. Andrade, Z. A., E. Peixoto, S. Guerret, and J. A. Grimaud. 1992. Hepatic connective tissue changes in hepatosplenic schistosomiasis. Hum. Pathol. 23:566-573.
4. Arinola, O. G., L. Salawu, and O. Ojurongbe. 2005. Immunoglobulin classes (IgG, IgA and IgM) and acute phase proteins in pregnant women with urinary schistosomiasis. West Afr. J. Med. 24:44-48.
5. Blanc, J. F., C. Lalanne, C. Plomion, J. M. Schmitter, K. Bathany, J. M. Gion, P. Bioulac-Sage, C. Balabaud, M. Bonneu, and J. Rosenbaum. 2005. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics 5:3778-3789.
6. Boehme, M. W., P. K. Kataaha, and E. J. Holborow. 1989. Autoantibodies to intermediate filaments in sera of patients with Schistosoma mansoni infection. Clin. Exp. Immunol. 77:230-233.
7. Brown, H. W. 1975. Basic clinical parasitology, 4th ed., p. 239-252. Appleton-Century-Crofts, New York, NY.
8. Brunet, L. R., F. D. Finkelman, A. W. Cheever, M. A. Kopf, and E. J. Pearce. 1997. IL-4 protects against TNF-alpha-mediated cachexia and death during acute schistosomiasis. J. Immunol. 159:777-785.
9. Butterworth, A. E., A. J. Curry, D. W. Dunne, A. J. Fulford, G. Kimani, H. C. Kariuki, R. Klumpp, D. Koech, G. Mbugua, J. H. Ouma, et al. 1994. Immunity and morbidity in human schistosomiasis mansoni. Trop. Geogr. Med. 46:197-208.
10. Cesaratto, L., C. Vascotto, C. D'Ambrosio, A. Scaloni, U. Baccarani, I. Paron, G. Damante, S. Calligaris, F. Quadrifoglio, C. Tiribelli, and G. Tell. 2005. Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver. Free Radic. Res. 39:255-268.
11. Chen, F., W. Cai, Z. Chen, X. Chen, and R. Liu. 2002. Dynamic changes in the collagen metabolism of liver fibrosis at the transcription level in rabbits with Schistosomiasis japonica. Chin. Med. J. (Engl. Ed.). 115:1637-1640.
12. Chiaramonte, M. G., D. D. Donaldson, A. W. Cheever, and T. A. Wynn. 1999. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Investig. 104:777-785.
13. Chiaramonte, M. G., M. Mentink-Kane, B. A. Jacobson, A. W. Cheever, M. J. Whitters, M. E. Goad, A. Wong, M. Collins, D. D. Donaldson, M. J. Grusby, and T. A. Wynn. 2003. Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J. Exp. Med. 197:687-701.
14. Cuezva, J. M., M. Krajewska, M. L. de Heredia, S. Krajewski, G. Santamaria, H. Kim, J. M. Zapata, H. Marusawa, M. Chamorro, and J. C. Reed. 2002. The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res. 62:6674-6681.
15. Czaja, M. J., F. R. Weiner, S. Takahashi, M. A. Giambrone, P. H. van der Meide, H. Schellekens, L. Biempica, and M. A. Zern. 1989. Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology 10:795-800.
16. Doenhoff, M. J., S. Pearson, D. W. Dunne, Q. Bickle, S. Lucas, J. Bain, R. Musallam, and O. Hassounah. 1981. Immunological control of hepatotoxicity and parasite egg excretion in Schistosoma mansoni infections: stage specificity of the reactivity of immune serum in T-cell deprived mice. Trans. R. Soc. Trop. Med. Hyg. 75:41-53.
17. el-Haieg, M. O., M. M. Enein, M. A. Mustafa, M. I. el-Khodary, M. A. Refaat, I. A. Ibrahim, and M. A. Abul-Fadl. 1978. Studies on certain serum enzymatic activities in hepatosplenic bilharziasis. Egypt. J. Bilharz. 5:19-28.
18. El-Koraie, A. F., N. M. Baddour, A. G. Adam, E. H. El-Kashef, and A. M. El Nahas. 2002. Cytoskeletal protein expression and regenerative markers in schistosomal nephropathy. Nephrol. Dial. Transplant. 17:803-812.
19. Elliott, D. E. 1996. Schistosomiasis. Pathophysiology, diagnosis, and treatment. Gastroenterol. Clin. N. Am. 25:599-625.
20. Fahim, F. A., E. W. Mohareb, N. S. Mansour, and A. M. Nour. 1988. Effect of immature Schistosoma mansoni worms on hamsters' plasma enzymes. Comp. Biochem. Physiol. B 90:851-854.
21. Fallon, P. G., E, J. Richardson, G. J. McKenzie, and A. N. McKenzie. 2000. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J. Immunol. 164:2585-2591.
22. Fella, K., M. Gluckmann, J. Hellmann, M. Karas, P. J. Kramer, and M. Kroger. 2005. Use of two-dimensional gel electrophoresis in predictive toxicology: identification of potential early protein biomarkers in chemically induced hepatocarcinogenesis. Proteomics 5:1914-1927.
23. Fitzner, B., H. Walzel, G. Sparmann, J. Emmrich, S. Liebe, and R. Jaster. 2005. Galectin-1 is an inductor of pancreatic stellate cell activation. Cell. Signal. 17:1240-1247.
24. Freyria, A. M., M. C. Ronziere, M. M. Boutillon, and D. Herbage. 1995. Effect of retinoic acid on protein synthesis by foetal bovine chondrocytes in high-density culture: down-regulation of the glucose-regulated protein, GRP-78, and type II collagen. Biochem. J. 305:391-396.
25. Fujii, K., T. Kondo, H. Yokoo, T. Yamada, K. Iwatsuki, and S. Hirohashi. 2005. Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye. Proteomics 5:1411-1422.
26. Gharib, B., O. M. Abdallahi, H. Dessein, and M. De Reggi. 1999. Development of eosinophil peroxidase activity and concomitant alteration of the antioxidant defenses in the liver of mice infected with Schistosoma mansoni. J. Hepatol. 30:594-602.
27. Griffin, T. J., S. P. Gygi, T. Ideker, B. Rist, J. Eng, L. Hood, and R. Aebersold. 2002. Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol. Cell. Proteomics 1:323-333.
28. Grzych, J. M., E. Pearce, A. Cheever, Z. A. Caulada, P. Caspar, S. Heiny, F. Lewis, and A. Sher. 1991. Egg deposition is the major stimulus for the production of Th2 cytokines in murine Schistosomiasis mansoni. J. Immunol. 146:1322-1327.
29. Guangjin, S., J. Mingdao, L. Qiyang, X. Hui, H. Jiangming, and Y. Xiaomei. 2002. Study on histopathology, ultrasonography and some special serum enzymes and collagens for 38 advanced patients of schistosomiasis japonica. Acta Trop. 82:235-246.
30. Harrison, D. J., L. May, J. D. Hayes, and G. E. Neal. 1990. Glutathione S-transferase localization in aflatoxin B1-treated rat livers. Carcinogenesis 11:927-931.
31. Hesse, M., M. Modolell, A. C. La Flamme, M. Schito, J. M. Fuentes, A. W. Cheever, E. J. Pearce, and T. A. Wynn. 2001. Differential regulation of NOS-2 and arginase-1 by type-1/type-2 cytokines in vivo. Granuloma pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167:6533-6544.
32. Hirano, T., H. Kato, M. Maeda, Y. Gong, Y. Shou, M. Nakamura, J. Maeda, K. Yashima, Y. Kato, S. Akimoto, T. Ohira, M. Tsuboi, and N. Ikeda. 2005. Identification of postoperative adjuvant chemotherapy responders in non-small cell lung cancer by novel biomarker. Int. J. Cancer 117:460-468.
33. Ho, D. W., S. T. Fan, J. To, Y. H. Woo, Z. Zhang, C. Lau, and J. Wong. 2002. Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model. Gut 50:869-876.
34. Hoffmann, K. F., T. C. McCarty, D. H. Segal, M. Chiaramonte, M. Hesse, E. M. Davis, A. W. Cheever, P. S. Meltzer, H. C. Morse III, and T. A. Wynn. 2001. Disease fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type 1 and type 2 cytokine-mediated inflammatory reactions. FASEB J. 15:2545-2547.
35. 2+-binding proteins localised to the secretory pathway of mammalian cells. FEBS Lett. 466:11-18.
36. +-transporting ATP-synthase in ovine ceroid-lipofuscinosis. Electrophoresis 22:1785-1794.
37. Kent, J., M. Lee, A. Schedl, S. Boyle, J. Fantes, M. Powell, N. Rushmere, C. Abbott, V. van Heyningen, and W. A. Bickmore. 1997. The reticulocalbin gene maps to the WAGR region in human and to the Small eye Harwell deletion in mouse. Genomics 42:260-267.
38. Kinoshita, M., and M. Miyata. 2002. Underexpression of mRNA in human hepatocellular carcinoma focusing on eight loci. Hepatology 36:433-438.
39. La Flamme, A. C., E. A. Patton, B. Bauman, and E. J. Pearce. 2001. IL-4 plays a crucial role in regulating oxidative damage in the liver during schistosomiasis. J. Immunol. 166:1903-1911.
40. Liang, C. R., C. K. Leow, J. C. Neo, G. S. Tan, S. L. Lo, J. W. Lim, T. K. Seow, P. B. Lai, and M. C. Chung. 2005. Proteome analysis of human hepatocellular carcinoma tissues by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 5:2258-2271.
41. Mahmoud, O. M., F. Elsamani, A. A. Gameel, and M. G. Taylor. 1987. Serum enzyme changes in calves experimentally infected with Schistosoma bovis. J. Comp. Pathol. 97:335-339.
42. Martinez, J. A., S. Prevot, B. Nordlinger, T. M. Nguyen, Y. Lacarriere, A. Munier, I. Lascu, J. C. Vaillant, J. Capeau, and M. L. Lacombe. 1995. Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages. Gut 37:712-720.
43. + T cells correlates with Th1/Th2 phenotype. J. Immunol. 160:5347-5354.
44. Neumann, C. A., D. S. Krause, C. V. Carman, S. Das, D. P. Dubey, J. L. Abraham, R. T. Bronson, Y. Fujiwara, S. H. Orkin, and R. A. Van Etten. 2003. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424:561-565.
45. Panes, J., X. Soler, A. Pares, J. Caballeria, J. Farres, J. Rodes, and X. Pares. 1989. Influence of liver disease on hepatic alcohol and aldehyde dehydrogenases. Gastroenterology 97:708-714.
46. Park, K. S., S. Y. Cho, H. Kim, and Y. K. Paik. 2002. Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma. Int. J. Cancer 97:261-265.
47. Pearce, E. J., A. Cheever, S. Leonard, M. Covalesky, R. Fernandez-Botran, G. Kohler, and M. Kopf. 1996. Schistosoma mansoni in IL-4-deficient mice. Int. Immunol. 8:435-444.
48. Rotenberg, Z., I. Weinberger, E. Davidson, J. Fuchs, D. Harell, and J. Agmon. 1989. Lactate dehydrogenase isoenzyme patterns in serum of patients with metastatic liver disease. Clin. Chem. 35:871-873.
49. Saber, M. A., D. A. Shafritz, and M. A. Zern. 1983. Changes in collagen and albumin mRNA in liver tissue of mice infected with Schistosoma mansoni as determined by in situ hybridization. J. Cell Biol. 97:986-992.
50. Sadano, H., S. Taniguchi, T. Kakunaga, and T. Baba. 1988. cDNA cloning and sequence of a new type of actin in mouse B16 melanoma. J. Biol. Chem. 263:15868-15871.
51. Sakai, H., T. Tsukamoto, M. Yamamoto, K. Kobayashi, H. Yuasa, T. Imai, T. Yanai, T. Masegi, and M. Tatematsu. 2002. Distinction of carcinogens from mutagens by induction of liver cell foci in a model for detection of initiation activity. Cancer Lett. 188:33-38.
52. Salah, L. A., A. A. Kheireldin, M. M. Mansour, and F. Hussein. 1976. Levels of some serum enzymes in patients with schistosomiasis. J Trop. Med. Hyg. 79:270-274.
53. Sanchez, J. C., D. Chiappe, V. Converset, C. Hoogland, P. A. Binz, S. Paesano, R. D. Appel, S. Wang, M. Sennitt, A. Nolan, M. A. Cawthorne, and D. F. Hochstrasser. 2001. The mouse SWISS-2D PAGE database: a tool for proteomics study of diabetes and obesity. Proteomics 1:136-163.
54. Sandler, N. G., M. M. Mentink-Kane, A. W. Cheever, and T. A. Wynn. 2003. Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J. Immunol. 171:3655-3667.
55. Santucci, L., S. Fiorucci, F. Cammilleri. G. Servillo. B. Federici, and A. Morelli. 2000. Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice. Hepatology 31:399-406.
56. Shahin, M., D. Schuppan, R. Waldherr, J. Risteli, L. Risteli, E. R. Savolainen, C. Oesterling, H. M. Abdel Rahman, A. M. el Sahly, S. M. Abdel Razek, et al. 1992. Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease. Hepatology 15:637-644.
57. Shau, H., A. Merino, L. Chen, C. C. Shih, and S. D. Colquhoun. 2000. Induction of peroxiredoxins in transplanted livers and demonstration of their in vitro cytoprotection activity. Antioxid. Redox. Signal. 2:347-354.
58. Sheweita, S. A., F. G. El-Shahat, M. A. Bazeed, M. R. Abu El-Maati, and P. J. O'Connor. 2004. Effects of Schistosoma haematobium infection on drug-metabolizing enzymes in human bladder cancer tissues. Cancer Lett. 205:15-21.
59. Sheweita, S. A., M. H. Mostafa, F. Ebid, and W. El-Sayed. 2003. Changes in expression and activity of glutathione S-transferase in different organs of schistosoma haematobium-infected hamster. J. Biochem. Mol. Toxicol. 17:138-145.
60. Shimonishi, T., K. Miyazaki, N. Kono, H. Sabit, K. Tuneyama, K. Harada, J. Hirabayashi, K. Kasal, and Y. Nakanuma. 2001. Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma. Hum. Pathol. 32:302-310.
61. Stickel, F., D. Schuppan, E. G. Hahn, and H. K. Seitz. 2002. Cocarcinogenic effects of alcohol in hepatocarcinogenesis. Gut 51:132-139.
62. Stillman, B. N., D. K. Hsu, M. Pang, C. F. Brewer, P. Johnson, F. T. Liu, and L. G. Baum. 2006. Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J. Immunol. 176:778-789.
63. Tabuchi, S., T. Gotoh, K. Miyanaka, K. Tomita, and M. Mori. 2000. Regulation of genes for inducible nitric oxide synthase and urea cycle enzymes in rat liver in endotoxin shock. Biochem. Biophys. Res. Commun. 268:221-224.
64. Takase, S., A. Takada, M. Yasuhara, and M. Tsutsumi. 1989. Hepatic aldehyde dehydrogenase activity in liver diseases, with particular emphasis on alcoholic liver disease. Hepatology 9:704-709.
65. Tanabe, M., N. Kaneko, and T. Takeuchi. 1989. Schistosoma mansoni: suppression of carbamoyl phosphate synthetase (ammonia) and ornithine carbamoyltransferase activities in the liver of infected mice. Exp. Parasitol. 68:432-442.
66. Thome-Kromer, B., I. Bonk, M. Klatt, G. Nebrich, M. Taufmann, S. Bryant, U. Wacker, and A. Kopke. 2003. Toward the identification of liver toxicity markers: a proteome study in human cell culture and rats. Proteomics 3:1835-1862.
67. van den Berg, T. K., H. Honing, N. Franke, A. van Remoortere, W. E. Schiphorst, F. T. Liu, A. M. Deelder, R. D. Cummings, C. H. Hokke, and I. van Die. 2004. LacdiNAc-glycans constitute a parasite pattern for galectin-3-mediated immune recognition. J. Immunol. 173:1902-1907.
68. Vidal, F., R. Toda, C. Gutierrez, M. Broch, F. Fernandez-Muixi, A. Lorenzo, and C. Richart. 1998. Influence of chronic alcohol abuse and liver disease on hepatic aldehyde dehydrogenase activity. Alcohol 15:3-8.
69. Wang, Y., E. Holmes, J. K. Nicholson, O. Cloarec, J. Chollet, M. Tanner, B. H. Singer, and J. Utzinger. 2004. Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc. Natl. Acad. Sci. USA 101:12676-12681.
70. Wei, S. J., C. S. Trempus, R. C. Ali, L. A. Hansen, and R. W. Tennant. 2004. 12-O-tetradecanoylphorbol-13-acetate and UV radiation-induced nucleoside diphosphate protein kinase B mediates neoplastic transformation of epidermal cells. J. Biol. Chem. 279:5993-6004.
71. Weiner, F. R., M. J. Czaja, M. A. Giambrone, S. Takahashi, L. Biempica, and M. A. Zern. 1987. Transcriptional and posttranscriptional effects of dexamethasone on albumin and procollagen messenger RNAs in murine schistosomiasis. Biochemistry 26:1557-1562.
72. Yu, L. R., R. Zeng, X. X. Shao, N. Wang, Y. H. Xu, and Q. C. Xia. 2000. Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis 21:3058-3068.
73. Zamotrinskii, A. V., I. Malyshev, and F. Z. Meerson. 1992. Isoform pattern of inducible HSP 70 in the rat myocardium after heat shock. Biull. Eksp. Biol. Med. 113:586-587. [In Russian.]
74. Zern, M. A., M. A. Saber, and D. A. Shafritz. 1983. Molecular mechanisms for changes in hepatic protein synthesis induced by schistosomiasis infection in mice. Biochemistry 22:6072-6077.